Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $30,924 - $34,519
307 New
307 $31,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $5,140 - $6,292
-57 Reduced 9.45%
546 $60,000
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $95 - $114
-1 Reduced 0.17%
603 $58,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $433,958 - $483,520
-4,306 Reduced 87.7%
604 $65,000
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $47,170 - $55,522
487 Added 11.01%
4,910 $497,000
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $420,450 - $493,252
4,423 New
4,423 $485,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $60,323 - $72,911
591 New
591 $64,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $59,613 - $72,993
-516 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $21,348 - $23,617
183 Added 54.95%
516 $61,000
Q2 2021

Aug 17, 2021

BUY
$105.79 - $124.53 $35,228 - $41,468
333 New
333 $39,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $62,021 - $79,380
-810 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $35,242 - $51,533
-561 Reduced 40.92%
810 $64,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $590,552 - $657,422
-7,522 Reduced 84.58%
1,371 $119,000
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $311,974 - $338,276
-3,812 Reduced 30.0%
8,893 $745,000
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $330,656 - $385,645
4,537 Added 55.55%
12,705 $1.07 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $7,211 - $8,169
110 Added 1.37%
8,168 $572,000
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $19,459 - $23,475
-320 Reduced 3.82%
8,058 $591,000
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $482,321 - $532,338
8,378 New
8,378 $510,000
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $138,705 - $156,823
-2,465 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $36,663 - $39,252
683 Added 38.33%
2,465 $140,000
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $85,642 - $95,586
1,782
1,782 $301,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.